These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 733979)

  • 1. Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective.
    de Leeuw PW
    Drugs; 1996 Feb; 51(2):179-87. PubMed ID: 8808162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arachidonic acid metabolites, hypertension and arteriosclerosis.
    Weber PC; Siess W; Scherer B; Held E; Witzgall H; Lorenz R
    Klin Wochenschr; 1982 May; 60(10):479-88. PubMed ID: 6954329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal by prostaglandin E2 infusion of the effects of indomethacin on the excretion of nitrogenous compounds in the rat.
    Rowe DJ; Gedeon G
    Br J Exp Pathol; 1983 Jun; 64(3):306-11. PubMed ID: 6576805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do nonsteroidal anti-inflammatory drugs interfere with blood pressure control in hypertensive patients?
    Radack K; Deck C
    J Gen Intern Med; 1987; 2(2):108-12. PubMed ID: 3550008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of non-steroidal anti-inflammatory drugs on prostacyclin and thromboxane biosynthesis in patients with mild essential hypertension.
    Minuz P; Barrow SE; Cockcroft JR; Ritter JM
    Br J Clin Pharmacol; 1990 Oct; 30(4):519-26. PubMed ID: 2291866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a beta 1-blocking agent, atenolol, on blood pressure, plasma renin activity and prostaglandin F2 alpha excretion in patients with essential hypertension.
    Pitkäjärvi T; Ylitalo P; Metsä-Ketelä T; Vapaatalo H
    Acta Med Scand; 1979; 206(1-2):107-13. PubMed ID: 484251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol.
    Ylitalo P; Pitkäjärvi T; Pyykönen ML; Nurmi AK; Seppälä E; Vapaatalo H
    Clin Pharmacol Ther; 1985 Oct; 38(4):443-9. PubMed ID: 3899459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of plasma renin activity by indomethacin in man.
    Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
    Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of free arachidonic acid by furosemide in man as the cause of prostaglandin and renin release.
    Weber PC; Scherer B; Larsson C
    Eur J Pharmacol; 1977 Feb; 41(3):329-32. PubMed ID: 837974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prostaglandin synthesis inhibition on blood pressure and humoral factors in exercising, sodium-deplete normal man.
    Staessen J; Fagard R; Lijnen P; Moerman E; De Schaepdryver A; Amery A
    J Hypertens; 1983 Aug; 1(2):123-30. PubMed ID: 6397516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of inhibition of prostaglandin synthesis on plasma renin activity and blood pressure in essential hypertension.
    Ylitalo P; Pitkäjärvi T; Metsä-Ketelä T; Vapaatalo H
    Prostaglandins Med; 1978 Dec; 1(6):479-88. PubMed ID: 733979
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.